An Open-Label Exploratory Study of Fosigotifator in Participants With Vanishing White Matter Disease
An Open-Label Exploratory Study of Fosigotifator in Participants With Vanishing White Matter Disease
Recruiting · NCT05757141 · Registry updated 2026-09-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Open-Label Exploratory Study of Fosigotifator in Participants With Vanishing White Matter Disease | Leukoencephalopathies, brain disorder, central nervous system disorder, leukoencephalopathy with vanishing white matter 1, nervous system disorder, neurodegenerative disease | Recruiting | Phase 1 / Phase 2 | 2026-09-24 | NCT05757141 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Calico Life Sciences LLC | 3 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Amsterdam UMC, locatie VUmc /ID# 270955 | Amsterdam | Netherlands | 1 |
| Children's Hospital of Philadelphia | Philadelphia | United States | 434 |
| Massachusetts General Hospital /ID# 270960 | Boston | United States | 1 |
| McGill University Health Centre - Glen Site | Montreal | Canada | 1 |
| University of Utah /ID# 255624 | Salt Lake City | United States | 1 |